肝素结合蛋白早期诊断临床感染性疾病的研究进展  

Research Progress on Early Diagnosis of Clinical Infectious Diseases by Heparin-binding Protein

作　　者：郑文婷[1] 尹志军[1] 邓文成[1] Zheng Wenting;Yin Zhijun;Deng Wencheng(Department of Laboratory Medicine,Zhongshan Xiaolan People's Hospital(Zhongshan Fifth People's Hospital),Zhongshan 528415,Guangdong Province,China)

机构地区：[1]中山市小榄人民医院(中山市第五人民医院)检验科,广东中山528415

出　　处：《中外医药研究》2025年第10期163-165,共3页JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH

摘　　要：该文综述肝素结合蛋白(HBP)早期诊断感染性疾病的研究进展,为临床医师提供新的诊断工具和治疗思路,提高感染性疾病的早期诊断准确率和治疗效果。通过检测HBP的浓度,不仅可以实现对脓毒症、泌尿系统感染、细菌性颅内感染、肺部感染、新生儿感染性疾病、肝硬化合并自发性腹膜炎以及急性胰腺炎并发感染等情况的早期识别,还能有效评估其严重程度和预后。This article reviewed the research progress of heparin-binding protein(HBP)in the early diagnosis of infectious diseases,providing clinicians with new diagnostic tools and treatment ideas,and improving the accuracy of early diagnosis and treatment effect of infectious diseases.By detecting the concentration of HBP,not only can the early identification of conditions such as sepsis,urinary tract infection,bacterial intracranial infection,pulmonary infection,neonatal infectious diseases,liver cirrhosis complicated with spontaneous peritonitis,and acute pancreatitis complicated with infection be achieved,but also the severity and prognosis can be effectively evaluated.

关 键 词：感染性疾病 早期诊断 肝素结合蛋白 研究进展 

分 类 号：R459.7[医药卫生—急诊医学]